Interferon-γ enhances the antifibrotic effects of pirfenidone by attenuating IPF lung fibroblast activation and differentiation

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) pathogenesis involves multiple pathways, and combined antifibrotic therapy is needed for future IPF therapy. Inhaled interferon-γ (IFN-γ) was recently shown to be safe and without systemic effects in patients with IPF. AIM: To examine the in vitro effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Vu, Tuong N., Chen, Xuesong, Foda, Hussein D., Smaldone, Gerald C., Hasaneen, Nadia A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737625/
https://www.ncbi.nlm.nih.gov/pubmed/31511015
http://dx.doi.org/10.1186/s12931-019-1171-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737625/
https://www.ncbi.nlm.nih.gov/pubmed/31511015
http://dx.doi.org/10.1186/s12931-019-1171-2

Ejemplares similares